Congress marks breast cancer awareness, highlights racial health disparities
H.Res. 806 — Supporting the recognition of October 2025 as "National Breast Cancer Awareness Month". · Filed by Buddy Carter (R-GA) · 4 cosponsors · Introduced Oct 14, 2025 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This is a symbolic House resolution supporting the recognition of October 2025 as National Breast Cancer Awareness Month. It does not create law, allocate funds, or change policy—it is a statement of support that acknowledges the public health burden of breast cancer, highlights disparities in diagnosis and survival rates across racial and ethnic groups, and calls on policymakers to address issues affecting the breast cancer community.
Why we flagged it
This is a non-binding symbolic resolution designating a month for public awareness and advocacy. It contains no legislative mechanism, appropriation, or regulatory change—only a statement of support and implicit call for future policy action.
What the text implies
- The resolution's emphasis on health disparities (Black women diagnosed later, higher mortality; American Indian/Alaska Native women with stable/rising rates) may create political pressure for targeted funding or policy changes, though the resolution itself does not mandate them.
- The mention of 'policymakers are urged to address the issues impacting the breast cancer community' is hortatory language that may signal future legislative intent by the sponsors, but carries no binding force.
Who it affects
This resolution raises public awareness of a significant health issue and explicitly highlights health disparities affecting Black women, Hispanic women, and American Indian/Alaska Native women. It creates no direct costs to citizens and may encourage policy attention to underserved populations and research funding.
Who stands to gain
- pharmaceutical companies (oncology divisions)
- cancer research institutions
- diagnostic imaging providers
- cancer treatment centers
Named in the bill
House of Representatives, Committee on Oversight and Government Reform, National Breast Cancer Awareness Month, BMY (Bristol Myers Squibb), GH (Guardant Health), PFE (Pfizer), DVA (DaVita), JNJ (Johnson & Johnson)
Where it stands
4 cosponsors: 3 Democrats, 1 Republicans.
- Oct 14, 2025 — Referred to House Committee on Oversight and Government Reform · Congress.gov: “Referred to the House Committee on Oversight and Government Reform”
Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.
How this was measured
Analysis — Quorum's AI read the full bill text on Jul 6, 2026; transparency and hidden-provision scores are compared against the median of 16,222 analysed bills.
Status and sponsors — Congress.gov's bill record — actions, committee referrals and cosponsors — loaded nightly. The timeline shows status changes, not every procedural action.
As of — page rendered 2026-10-20.
“Congress marks breast cancer awareness, highlights racial health disparities” QuorumCivic. https://share.quorumcivic.app/bill/119/hres806 Report an error
The week in bills
One email, Sunday: what Congress passed, what it changed, and who paid.
One link arrives to confirm the address. It is used for this email and nothing else, and every issue carries an unsubscribe link.